Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
Report ID | 128660 |
Drug Identification Number | 02486636 |
Brand name | SODIUM BICARBONATE INJECTION, USP |
Common or Proper name | Sodium Bicarbonate Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM BICARBONATE |
Strength(s) | 84MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 8.4%, 50 mEq (mmol), 50 mL Vial |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-11-30 |
Actual start date | |
Estimated end date | 2021-01-04 |
Actual end date | 2021-01-11 |
Shortage status | Resolved |
Updated date | 2021-01-12 |
Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that our Sodium Bicarbonate Injection, USP 8.4% 50 mEq (mmol) Vial 50 mL will be available at Ontario distribution centers today, Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-01-12 | English | Compare |
v5 | 2021-01-11 | French | Compare |
v4 | 2021-01-11 | English | Compare |
v3 | 2020-12-01 | English | Compare |
v2 | 2020-11-20 | French | Compare |
v1 | 2020-11-20 | English | Compare |
Showing 1 to 6 of 6